Veeva Systems Partners with Amgen to Transform Clinical Trial Processes

Collaboration to Revolutionize Clinical Trials

Veeva Systems, well-known for its cloud software solutions, has entered into a significant partnership with Amgen, a leading global biotech firm. This collaboration aims to innovate the clinical trial process, enabling a more efficient pathway to developing new medications for patients grappling with severe diseases. The partnership centers around the deployment of the Veeva Clinical Platform, which is poised to enhance various aspects of clinical operations.

Streamlining Clinical Operations

The Veeva Clinical Platform is lauded for being a comprehensive solution that integrates several key components of clinical operations, including Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC), site connectivity, and advanced analytics, among others. Through this integration, Veeva and Amgen aim to identify efficiencies throughout the clinical trial lifecycle—from study initiation to study closeout. This synergy presents an opportunity to significantly accelerate timelines for getting life-saving therapies into the hands of patients.

Scott Skellenger, Amgen's Senior VP and CIO, expressed excitement about this collaboration, emphasizing that it will empower Amgen with innovative capabilities to enhance their trial operations. By leveraging Veeva's cutting-edge technology, Amgen expects to enhance their operational efficiencies and navigate the complexities of clinical trials at unprecedented speed and scale.

Advanced Technology Driving Innovation

At the core of this collaboration lies Veeva's commitment to delivering advanced technology solutions tailored for the life sciences industry. The Veeva Clinical Platform is designed to streamline processes through increased connectivity and standardized workflows. This comprehensive integration not only facilitates better data management but also improves the overall experience for clinical trial participants and researchers.

Jim Reilly, President of Veeva Development Cloud, echoed these sentiments, highlighting the platform’s role as a backbone for clinical processes. His statement accentuates the promise of this partnership, reiterating that by working together, both organizations can foster faster delivery of potential treatments, significantly impacting patient lives.

Support and Implementation

As part of this strategic collaboration, Veeva's Business Consulting team will provide essential support to Amgen during the implementation phase. This includes change management strategies designed to help seamlessly integrate Veeva’s clinical technology solutions into Amgen's existing operations. This hands-on support underscores the commitment from Veeva to ensure that Amgen reaps the full benefits of their innovative platform.

The Future of Clinical Trials

The partnership between Veeva Systems and Amgen signifies a profound shift in how clinical trials might be conducted moving forward. With a focus on harnessing the power of interconnected systems, both companies are advocating for a new era of clinical research where efficiency, speed, and patient-centric approaches reign supreme. As the pharmaceutical landscape continues to evolve, this collaboration sets a benchmark for future partnerships in the industry.

Interested parties can find more detailed information about the Veeva Clinical Platform at veeva.com/VeevaClinicalPlatform. Veeva Systems is committed to fostering innovation within the life sciences sector, serving over 1,500 clients globally, ranging from large pharmaceutical firms to emerging biotech companies.

In conclusion, this essential collaboration between Veeva and Amgen not only aims to reshape the clinical trial landscape but also promises to bring forth innovative treatments to those in need more rapidly—underscoring the shared commitment of both companies to patient welfare and medical advancement.